{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:16:44Z","timestamp":1790867804446,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T00:00:00Z","timestamp":1182297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2334-7-60","type":"journal-article","created":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T14:13:39Z","timestamp":1182348819000},"source":"Crossref","is-referenced-by-count":18,"title":["Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA"],"prefix":"10.1186","volume":"7","author":[{"name":"the PACTG 316 Study Team","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Newell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mandelbrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Maupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Delke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Heather","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D","family":"Gelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleen K","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,20]]},"reference":[{"key":"503_CR1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/0140-6736(92)90534-A","volume":"vol. 339","author":"European Collaborative Study","year":"1992","unstructured":"European Collaborative Study: Risk factors for mother-to-child transmission of HIV-1. Lancet. 1992, vol. 339: 1007-1012. 10.1016\/0140-6736(92)90534-A.","journal-title":"Lancet"},{"key":"503_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJM198906223202502","volume":"320","author":"S Blanche","year":"1989","unstructured":"Blanche S, Rouzioux C, Moscato ML, Veber F, Mayaux MJ, Jacomet C, Tricoire J, Deville A, Vial M, Firtion G: A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N Engl J Med. 1989, 320: 1643-1648.","journal-title":"N Engl J Med"},{"key":"503_CR3","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJM199606203342501","volume":"334","author":"SH Landesman","year":"1996","unstructured":"Landesman SH, Kalish LA, Minkoff HL, Fox HE, Zorrilla C, Garcia PM, Fowler MG, Mofenson LM, Tuomala RE, The Women and Infants Transmission Study: Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother-to-child. N Eng J Med. 1996, 334: 1617-1623. 10.1056\/NEJM199606203342501.","journal-title":"N Eng J Med"},{"key":"503_CR4","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/00002030-199308000-00027","volume":"7","author":"F Dabis","year":"1993","unstructured":"Dabis F, Msellati P, Dunn DT, Lepage P, Newell ML, Perre P, Working Group on Mother-to-Child Transmission of HIV: Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues, Ghent (Belgium), 17-20 February 1992. AIDS. 1993, 7: 1139-1148. 10.1097\/00002030-199308000-00027.","journal-title":"AIDS"},{"key":"503_CR5","first-page":"298","volume":"6","author":"P Nair","year":"1993","unstructured":"Nair P, Alger L, Hines S, Seiden S, Hebel R, Johnson JP: Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acquir Immune Defic Syndr. 1993, 6: 298-302.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"503_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/BF01959360","volume":"151","author":"C Kind","year":"1992","unstructured":"Kind C, Brandle B, Wyler CA, Calame A, Rudin C, Schaad UB, Schupbach J, Senn HP, Perrin L, Matter L, The Swiss Neonatal HIV Study Group: Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Eur J Pediatr. 1992, 151: 442-448. 10.1007\/BF01959360.","journal-title":"Eur J Pediatr"},{"key":"503_CR7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1542\/peds.96.3.451","volume":"96","author":"EJ Abrams","year":"1995","unstructured":"Abrams EJ, Matheson PB, Thomas PA, Thea DM, Krasinski K, Lambert G, Shaffer N, Bamji M, Hutson DG, Grimm K, Kaur A, Rogers MF, New York City Perinatal HIV Transmission Collaborative Study Group: Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. Pediatrics. 1995, 96: 451-458.","journal-title":"Pediatrics"},{"key":"503_CR8","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1097\/01.aids.0000233576.33973.b3","volume":"20","author":"European Collaborative Study","year":"2006","unstructured":"European Collaborative Study: The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West. AIDS. 2006, 20: 1419-1427.","journal-title":"AIDS"},{"key":"503_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1097\/00002030-199410000-00019","volume":"8","author":"RW Ryder","year":"1994","unstructured":"Ryder RW, Behets F: Reasons for the wide variation in reported rates of mother-to-child transmission of HIV-1. AIDS. 1994, 8: 1495-1497.","journal-title":"AIDS"},{"key":"503_CR10","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2105\/AJPH.94.7.1147","volume":"94","author":"MH Cohen","year":"2004","unstructured":"Cohen MH, Cook JA, Grey D, Young M, Hanau LH, Tien P, Levine AM, Wilson TE: Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. Am J Public Health. 2004, 94: 1147-1151.","journal-title":"Am J Public Health"},{"key":"503_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1097\/00002030-199711000-00011","volume":"11","author":"FF Hamers","year":"1997","unstructured":"Hamers FF, Batter V, Downs AM, Alix J, Cazein F, Brunet JB: The HIV epidemic associated with injecting drug use in Europe: geographic and time trends. AIDS. 1997, 11: 1365-1374. 10.1097\/00002030-199711000-00011.","journal-title":"AIDS"},{"key":"503_CR12","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00002030-199612000-00012","volume":"10","author":"European Collaborative Study","year":"1996","unstructured":"European Collaborative Study: Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS. 1996, 10: 1675-1681.","journal-title":"AIDS"},{"key":"503_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0140-6736(04)16594-X","volume":"364","author":"FF Hamers","year":"2004","unstructured":"Hamers FF, Downs AM: The changing face of the HIV epidemic in western Europe: what are the implications for public health policies?. The Lancet. 2004, 364: 83-94. 10.1016\/S0140-6736(04)16594-X.","journal-title":"The Lancet"},{"key":"503_CR14","volume-title":"Slide Series www cdc gov\/hiv\/graphics\/women htm","author":"Centers For Disease Control and Prevention","year":"2004","unstructured":"Centers For Disease Control and Prevention: HIV\/AIDS Surveillance in Women. Slide Series www cdc gov\/hiv\/graphics\/women htm. 2004, L264:"},{"key":"503_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00126334-200306010-00019","volume":"33","author":"KL Dominguez","year":"2003","unstructured":"Dominguez KL, Lindegren ML, D'Almada PJ, Peters VB, Frederick T, Rakusan TA, Ortiz IR, Hsu HW, Melville SK, Sadek R, Fowler MG: Increasing Trend of Cesarean Deliveries in HIV-Infected Women in the United States From 1994 to 2000. J Acquir Immune Defic Syndr. 2003, 33: 232-238. 10.1097\/00126334-200306010-00019.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"503_CR16","first-page":"1","volume-title":"Enhanced Perinatal Surveillance - United States, 1999-2001","author":"Centers For Disease Control and Prevention","year":"2004","unstructured":"Centers For Disease Control and Prevention: Enhanced Perinatal Surveillance - United States, 1999-2001. 2004, Atlanta, US Department of Health and Human Sciences, 1-22. 4","edition":"4"},{"key":"503_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/00126334-200501010-00017","volume":"38","author":"KA Gebo","year":"2005","unstructured":"Gebo KA, Fleishman JA, Conviser R, Reilly ED, Korthuis PT, Moore RD, Hellinger J, Keiser P, Rubin HR, Crane L, Hellinger FJ, Mathews WC, Network HIVR: Racial and gender disparities in receipt of highly active antiretroviral therapy persist in multstate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005, 38: 96-103. 10.1097\/00126334-200501010-00017.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"503_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0033-3549(04)50158-9","volume":"117","author":"H Palacio","year":"2002","unstructured":"Palacio H, Kahn JG, Richards TA, Morin SF: Effect of race and\/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep. 2002, 117: 233-251.","journal-title":"Public Health Rep"},{"key":"503_CR19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1471-0528.1998.tb10199.x","volume":"105","author":"European Collaborative Study","year":"1998","unstructured":"European Collaborative Study: Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. Br J Obstet Gynaecol. 1998, 105: 704-709.","journal-title":"Br J Obstet Gynaecol"},{"key":"503_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/jama.288.2.189","volume":"288","author":"A Dorenbaum","year":"2002","unstructured":"Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson LM, Britto P, Rekacewicz C, Newell ML, Delfraissy JF, Cunningham-Schrader B, Mirochnick M, Sullivan JL, Team IPACTG: Two-dose intrapartum\/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission. A randomised trial. JAMA. 2002, 288: 189-198. 10.1001\/jama.288.2.189.","journal-title":"JAMA"},{"key":"503_CR21","first-page":"449","volume":"7","author":"S Fiore","year":"2003","unstructured":"Fiore S, Thorne C, Newell ML: European involvement in an international perinatal trial. Developmental Period Medicine. 2003, 7: 449-458.","journal-title":"Developmental Period Medicine"},{"key":"503_CR22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","volume":"331","author":"EM Connor","year":"1994","unstructured":"Connor EM, Sperling RS, Gelber RD, Kiselev P, Scott GB, O'Sullivan MJ, Van Dyke R, Bey M, Shearer WT, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy JF, Culnane M, Coombs RW, Elkins MM, Moye JJ, Stratton P, Balsey J: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Eng J Med. 1994, 331: 1173-1180. 10.1056\/NEJM199411033311801.","journal-title":"N Eng J Med"},{"key":"503_CR23","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/00126334-200302011-00007","volume":"32","author":"FF Hamers","year":"2003","unstructured":"Hamers FF, Infuso A, Alix J, Downs AM: Current situation and regional perspective on HIV\/AIDS surveillance in Europe. J Acquir Immune Defic Syndr. 2003, 32: S39-S48.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"503_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2307\/2135956","volume":"28","author":"WD Mosher","year":"1996","unstructured":"Mosher WD, Bachrach CA: Understanding U.S. fertility: continuity and change in the National Survey of Family Growth, 1988-1995. Fam Plann Perspect. 1996, 28: 4-12. 10.2307\/2135956.","journal-title":"Fam Plann Perspect"},{"key":"503_CR25","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0140-6736(97)04441-3","volume":"349","author":"The CAESAR Coordinating Committee","year":"1997","unstructured":"The CAESAR Coordinating Committee: Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial. Lancet. 1997, 349: 1413-1421. 10.1016\/S0140-6736(97)04441-3.","journal-title":"Lancet"},{"key":"503_CR26","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1001\/jama.1997.03540480062040","volume":"277","author":"CCJ Carpenter","year":"1997","unstructured":"Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JSG, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Volberding PA: Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA panel. JAMA. 1997, 277: 1962-1969. 10.1001\/jama.277.24.1962.","journal-title":"JAMA"},{"key":"503_CR27","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","volume":"29","author":"ER Cooper","year":"2002","unstructured":"Cooper ER, Charurat M, Mofenson LM, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner WA: Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002, 29: 484-494.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"503_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/00002030-200104130-00012","volume":"15","author":"European Collaborative Study","year":"2001","unstructured":"European Collaborative Study: HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS. 2001, 15: 761-770. 10.1097\/00002030-200104130-00012.","journal-title":"AIDS"},{"key":"503_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1001\/jama.280.1.55","volume":"280","author":"L Mandelbrot","year":"1998","unstructured":"Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla JL, Delfraissy JF, Blanche S, Mayaux MJ, Cohort FP: Perinatal HIV-1 Transmission - Interaction Between Zidovudine Prophylaxis and Mode of Delivery in the French Perinatal Cohort. JAMA. 1998, 280: 55-60. 10.1001\/jama.280.1.55.","journal-title":"JAMA"},{"key":"503_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0301-2115(03)00153-2","volume":"111","author":"European Collaborative Study","year":"2003","unstructured":"European Collaborative Study: Pregnancy-related changes in the longer-term management of HIV infected women in Europe. Eur J Obstet Gynecol Reprod Biol. 2003, 111: 3-8. 10.1016\/S0301-2115(03)00153-2.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"503_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/archpedi.156.9.915","volume":"156","author":"The Italian Register for HIV Infection in Children","year":"2002","unstructured":"The Italian Register for HIV Infection in Children: Determinants of mother-to-infant human immunodeficiency virus 1 transmission before and after the introduction of zidovudine prophylaxis. Arch Pediatr Adolesc Med. 2002, 156: 915-921.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"503_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1086\/427287","volume":"40","author":"European Collaborative Study","year":"2005","unstructured":"European Collaborative Study: Mother-to-child transmission of HIV Infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005, 40: 458-465. 10.1086\/427287.","journal-title":"Clin Infect Dis"},{"key":"503_CR33","first-page":"781","volume":"Abstract","author":"J Warszawski","year":"2005","unstructured":"Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, al : Is intrapartum intravenous zidovudine still beneficial to prevent mother-to-child HIV-1 transmission?. 12th Conference on Retroviruses and Opportunistic Infections, 22-25 February 2005, Boston, USA. 2005, Abstract: 781-","journal-title":"12th Conference on Retroviruses and Opportunistic Infections, 22-25 February 2005, Boston, USA"},{"key":"503_CR34","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1001\/jama.285.16.2083","volume":"285","author":"L Mandelbrot","year":"2001","unstructured":"Mandelbrot L, Landreau A, Rekacewicz C, Berrebi A, Benifla JL, Burgard M, Lachassine E, Chaix ML, Bongain A, Ciraru-Vigneron N, Crenn-Herbert C, Delfraissy JF, Rouzioux C, Mayaux MJ, Blanche S, the Agence Nationale de Recherches sur le SIDA ANRSG: Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1. JAMA. 2001, 285: 2083-2093. 10.1001\/jama.285.16.2083.","journal-title":"JAMA"},{"key":"503_CR35","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00126334-200407010-00006","volume":"36","author":"CK Cunningham","year":"2004","unstructured":"Cunningham CK, Balasubramanian R, Delke I, Maupin R, Mofenson L, Dorenbaum A, Sullivan JL, Gonzalez-Garcia A, Thorpe E, Rathore M, Gelber RD: The impact of race\/ethnicity on mother-to-child HIV transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316. J Acquir Immune Defic Syndr. 2004, 36: 800-807. 10.1097\/00126334-200407010-00006.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"503_CR36","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/00006454-200207000-00012","volume":"21","author":"SA Fiscus","year":"2002","unstructured":"Fiscus SA, Adimora AA, Funk ML, Schoenbach VJ, Tristram D, Lim W, McKinney RE, Rupar D, Woods C, Wilfert C: Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina. Pediatr Infect Dis J. 2002, 21: 664-668. 10.1097\/00006454-200207000-00012.","journal-title":"Pediatr Infect Dis J"},{"key":"503_CR37","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1001\/jama.281.20.1946","volume":"281","author":"JSA Stringer","year":"1999","unstructured":"Stringer JSA, Rouse DJ, Goldenberg RL: Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission. The case for restraint. JAMA. 1999, 281: 1946-1949. 10.1001\/jama.281.20.1946.","journal-title":"JAMA"},{"key":"503_CR38","first-page":"35","volume":"4","author":"N Brockmeyer","year":"1999","unstructured":"Brockmeyer N: German-Austrian Guidelines for HIV-therapy during pregnancy--status: May\/June 1998--common statement of the Deutsche AIDS-Gesellschaft (DAIG) and the Osterreichische AIDS-Gesellschaft (OAG). Eur J Med Res. 1999, 4: 35-42.","journal-title":"Eur J Med Res"},{"key":"503_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/sti.75.2.90","volume":"75","author":"GP Taylor","year":"1999","unstructured":"Taylor GP, Lyall EGH, Mercey D, Smith JR, Chester T, Newell ML, Tudor-Williams G: British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998). Sexually Transmitted Infections. 1999, 75: 90-97.","journal-title":"Sexually Transmitted Infections"},{"key":"503_CR40","first-page":"S1","volume":"16","author":"ML Newell","year":"2002","unstructured":"Newell ML, Rogers MF: Pregnancy and HIV infection: a European Consensus on management. AIDS. 2002, 16: S1-S18.","journal-title":"AIDS"},{"key":"503_CR41","first-page":"www.bhiva.org","volume-title":"Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV","author":"British HIV Association","year":"2005","unstructured":"British HIV Association: Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. 2005, London, British HIV Association, www.bhiva.org-"},{"key":"503_CR42","first-page":"1359","volume":"159","author":"C Hankins","year":"1998","unstructured":"Hankins C, Lapointe N, Walmsley S: Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group. CMAJ. 1998, 159: 1359-1365.","journal-title":"CMAJ"},{"key":"503_CR43","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1097\/01.aids.0000189866.67182.f7","volume":"19","author":"M Gandhi","year":"2005","unstructured":"Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, Gange SJ, Anastos K, Holman S, Levine A, Greenblatt RM: Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. AIDS. 2005, 19: 1885-1896. 10.1097\/01.aids.0000189866.67182.f7.","journal-title":"AIDS"},{"key":"503_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1468-1293.2000.00019.x","volume":"1","author":"DAJ Moore","year":"2000","unstructured":"Moore DAJ, Goodall RL, Ives NJ, Hooker M, Gazzard BG, Easterbrook PJ: How generalizable are the results of large randomized controlled trials of antiretroviral therapy?. HIV Medicine. 2000, 1: 149-154. 10.1046\/j.1468-1293.2000.00019.x.","journal-title":"HIV Medicine"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-7-60\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-60","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T08:41:47Z","timestamp":1683880907000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-7-60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,20]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-7-60","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,20]]},"article-number":"60"}}